Patents
Patents for C07C 211 - Compounds containing amino groups bound to a carbon skeleton (24,007)
02/2008
02/13/2008CN100368380C Tech. of preparing 3,3-dichlorobenzidine hydrochloride
02/13/2008CN100368379C Method for the production of isophorondiamine (IDPA, 3-aminomethyl-3,5,5-trimethylcyclohexylamine) having a high cis/trans-isomer ratio
02/13/2008CN100368378C Production process of o-trifluoromethyl aniline
02/12/2008CA2240971C Nonylated diphenylamines
02/07/2008WO2008016018A1 Organic electroluminescent device material and organic electroluminescent device using the same
02/07/2008WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/07/2008WO2008002853A3 Phenylacetic acid derivatives as cox-2 inhibitors
02/07/2008WO2007131498A3 Salts consisting of pentafluorphenylimide anions and their use as ionic liquids
02/07/2008US20080033226 Protecting catalytic sites of metalloaluminophosphate molecular sieves
02/07/2008US20080033212 Process for the Continuous Synthesis of Methylamines
02/07/2008US20080033210 Diimines and secondary diamines
02/07/2008US20080033193 Catalyst for selective hydrogenation of nitro groups of halonitro aromatic compounds
02/07/2008US20080033178 Ionic Liquids
02/07/2008US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
02/07/2008US20080033054 Process for preparing memantine hydrochloride substantially free of impurities
02/07/2008US20080033052 Dermal anesthetic compounds
02/07/2008US20080033051 crystallization by combining O-desmethylvenlafaxine starting material and solvent selected from ethanol, tetrahydrofuran, isopropyl alcohol, heating, dissolving, recovering; inhibits re-uptake of norepinephrine and serotonin; alternative to tricyclic anti-depressants and selective re-uptake inhibitors
02/07/2008US20080033044 Crystal form; controlled release tablet of bupropion hydrobromide for reducing the ratio of the maximum/minimum plasma bupropion hydrobromide concentration (Cmax/Cmin) while maintaining bupropion plasma levels within the therapeutic window upon administration to a patient; more stable than buproin hcl
02/07/2008US20080033043 Modified release formulations of a bupropion salt
02/07/2008CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/06/2008EP1883618A1 Processes for preparing cinacalcet hydrochloride crystal form i
02/06/2008CN101119962A Selective splitting of substituted bisbenzylamides and bisbenzylamines
02/06/2008CN101117319A Diamine, liquid crystal tropism agent, liquid crystal tropism film and liquid crystal display device
02/06/2008CN101117318A Fractional neutralization treating method of glyphosate mother liquor
02/06/2008CN100366602C Method for avoiding corrosion
02/05/2008US7326814 Minimization of volatile organic sulphur byproducts in dimethyl sulfate quaternization of amines made with hypophorous acid
02/05/2008US7326813 Process for producing benzylamine derivative
02/05/2008US7326746 Curable electron donor compositions
02/05/2008US7326730 Aminoadamantane derivatives as therapeutic agents
02/05/2008US7326724 Salts of omeprazole and esomeprazole I
02/05/2008US7326510 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
02/05/2008CA2284977C 3,3-disubstituted propylamines, their use and preparation
01/2008
01/31/2008WO2008013856A2 Methods and compositions for production, formulation and use of 1 aryl -3-azabicyclo[3.1.0 ] hexanes
01/31/2008WO2008012047A1 Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
01/31/2008WO2008012027A1 Insecticidal compounds
01/31/2008WO2007125034A3 Mono-nitration of aromatic compounds
01/31/2008WO2007107818A3 Process for the preparation of 3,5-bis (trifluoromethyl)-n-methylbenzylamine
01/31/2008US20080027230 reacting an onium chloride with an acid resulting in formation of hydrochloric acid, formed hydrochloric acid is removed by azeotropic distillation by coordination to 1,4-dioxane which forms an azeotropic mixture with water;
01/31/2008US20080025904 non-covalently linked complex comprising a high-order fullerene and two units of 2,7,12-Tris{N-[(amino-ethoxy)carbonyl]-6-undecanylisocytosine}-3,8,13-trime-thoxy-10,15-dihydro-5H-tribenzo[a,d,g]cyclononene
01/31/2008DE102006035203A1 Verfahren zur Herstellung von aromatischen Aminen A process for the preparation of aromatic amines
01/31/2008CA2657104A1 Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
01/30/2008EP1882681A1 Method for manufacturing aromatic amines
01/30/2008EP1882672A1 Method for producing deuterium gas and catalytic deuteration method using deuterium gas obtained thereby
01/30/2008EP1881963A1 Process for the preparation of a carboxamide derivative
01/30/2008EP1881954A2 Process for preparing cinacalcet hydrochloride
01/30/2008CN101115708A Aromatic amine derivative and organic electroluminescence device using the same
01/30/2008CN101115707A Removal of metal ions from onium hydroxides and onium salt solutions
01/30/2008CN101113136A Method for preparing sertraline hydrochloride
01/30/2008CN100364959C Process for the preparation of diamines and polyamines of the diphenylmethane series
01/30/2008CN100364958C Process for producing an amino composition
01/30/2008CN100364957C Method for the production of amines
01/29/2008US7323598 Preparation of xylylenediamine (XDA)
01/29/2008US7323597 Method for the production of diaminoxylene by continuous hydrogenation of liquid phthalonitrile
01/29/2008US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/29/2008CA2394808C Use of salt-like structured silicas as charge control agents
01/29/2008CA2220999C Process for the hydrogenation of imines
01/24/2008WO2008011539A2 Anesthetic compounds
01/24/2008WO2008011266A1 Ionic bronsted acid
01/24/2008WO2008011161A2 Dermal anesthetic compounds
01/24/2008WO2008010481A1 Aminoindan derivative or salt thereof
01/24/2008WO2008010043A2 Improved process for the preparation of ceforanide in pure form
01/24/2008WO2008010025A1 Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
01/24/2008WO2008009668A1 Direct amination of hydrocarbons
01/24/2008WO2008009275A1 Method for the production of chiral aminocarbonyl compounds
01/24/2008WO2007135562A3 Hydroxyphenyl derivatives and biological applications thereof
01/24/2008WO2007127421A3 Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes
01/24/2008US20080021126 Alpha-aminoketones derivatives with one or 2 hydroxyalkylaminobenzoyl groups, e.g., 2-benzyl-1-[4-(2-hydroxyethylamino)phenyl]-2-dimethylamino-1-butanone; reduced VOC emission before curing and migration and/or extraction of residual photoinitiator from cured product; high initiator efficiency; inks
01/24/2008US20080017853 Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative
01/24/2008DE102006031143A1 Fluortenside Fluorosurfactants
01/24/2008CA2658537A1 Method for the production of chiral aminocarbonyl compounds
01/24/2008CA2657636A1 Positively charged water-soluble pro-drugs of ibuprofen
01/24/2008CA2657121A1 Ionic bronsted acid
01/24/2008CA2656510A1 Anesthetic compounds
01/23/2008EP1880990A1 Novel organic electroluminescent material, organic electroluminescent element employing the same, and thin-film-forming solution for organic electroluminescence
01/23/2008EP1879849A1 Process for preparing memantine
01/23/2008EP1185366B1 Promoted porous catalyst
01/23/2008EP1137406B2 Transdermal patch for delivering volatile liquid drugs
01/23/2008CN101111472A Tetralin and indane derivatives and uses thereof
01/23/2008CN101111469A Method for producing bis-[(3-dimethylamino)propyl]amine (bisdmapa)
01/23/2008CN101111468A Method for producing bis-[(3-dimethylamino)propyl]amine (dipropylene triamine, dpta)
01/23/2008CN101111454A Method for producing deuterium gas and catalytic deuteration method using deuterium gas obtained thereby
01/23/2008CN101108861A Salts comprising cyanoborate anions
01/23/2008CN101108808A 1-methyl-4[4-(N,N-p-methylphenyl amido)styryl]naphthyl and method of manufacturing the same and application thereof
01/23/2008CN101108807A 1,4 di[4-(N,N-p-methylphenyl amido)styryl]naphthyl and method of manufacturing the same and application thereof
01/23/2008CN101108806A Technique for synthesizing tert-butylamine
01/23/2008CN101108759A Salts comprising cyanoborate anions
01/23/2008CN100363369C Laminated organic-inorganic perofskite with metal defect inorganic frame
01/23/2008CN100363330C Method for improving 4-amino diphenylamine yield
01/23/2008CN100363329C Method of synthesizing amantadine hydrochloride
01/22/2008US7321068 Method for producing tricyclodecandialdehyde
01/22/2008US7321066 Method for producing aromatic diamine derivative
01/22/2008US7321065 E.g., N-methyl-O-benzyl-tyramine, 3,5,3',5'-tetraiodothyroethanolamine; antagonist of a G protein coupled receptor and a trace amine receptor; antidepressants; nervous system disorders; antidiabetic agents; antiarrhymia disorders; glandular disorders of the thyroid; congestive heart failure; analgesics
01/22/2008US7320998 Carbohydrate analog inhibitors of alpha-amylase
01/22/2008CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance
01/22/2008CA2172946C N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate
01/17/2008WO2008008697A2 Compositions, methods and uses for sterically-hindered quaternary ammonium compounds
01/17/2008WO2008007696A1 Method for producing fluoroamine
01/17/2008WO2008007670A1 Fluoroboron compound, aminomethylating agent for aromatic ring comprising the compound, and process for production of compound having aminomethyl-aromatic ring using the aminomethylating agent
01/17/2008WO2008007171A1 Positively charged water-soluble prodrugs of aspirin
01/17/2008WO2008006864A1 Method for producing optically active amines
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 241